Cover Image

Design, synthesis, and biological evaluation of 3-vinyl-quinoxalin-2(1H)-one derivatives as novel antitumor inhibitors of FGFR1

Zhiguo Liu,1,* Shufang Yu,1,* Di Chen,1 Guoliang Shen,1 Yu Wang,1 Leping Hou,2 Dan Lin,1 Jinsan Zhang,1 Faqing Ye1 1School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 2Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People’s Republic of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liu Z (Author), Yu S (Author), Chen D (Author), Shen G (Author), Wang Y (Author), Hou L (Author), Lin D (Author), Zhang JS (Author), Ye F (Author)
Format:	Book
Published:	Dove Medical Press, 2016-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synthesis and biological evaluation of quinoxaline derivatives as ASK1 inhibitors
by: Xiaorui Han, et al.
Published: (2024)

Design, synthesis and biological evaluation of novel 2-hydroxy-1 H-indene-1,3(2 H)-dione derivatives as FGFR1 inhibitors
by: Mohammed M. Al-Mahadeen, et al.
Published: (2024)

Synthesis, biological evaluations and molecular modelling studies of novel indolin-2-ones designing as FGFR inhibitors
by: Güneş Çoban, et al.
Published: (2019)

Design, synthesis and biological evaluation of novel 1H-1,2,4-triazole, benzothiazole and indazole-based derivatives as potent FGFR1 inhibitors viafragment-based virtual screening
by: Jian Liu, et al.
Published: (2020)

Synthesis and evaluation of some new 1,2,4-triazolo(4,3-a)quinoxalin-4-5H-one derivatives as AMPA receptor antagonists
by: Ashraf Bayoumi, et al.
Published: (2012)

Cyclophilin J PPIase Inhibitors Derived from 2,3-Quinoxaline-6 Amine Exhibit Antitumor Activity
by: Xuemei Zhao, et al.
Published: (2018)

Quinoxaline 1, 4-di-N-oxides: Biological activities and mechanisms of actions
by: Guyue eCheng, et al.
Published: (2016)

Prediction of biological activity of spiroquinazolone derivatives as protein kinase inhibitors FGFR1 and CK2
by: O. K. Farat, et al.
Published: (2020)

Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer
by: Zixin Xie, et al.
Published: (2018)

Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors
by: Xiaowei Wu, et al.
Published: (2021)

Facile Entry to Pharmaceutically Important 3-Difluoromethyl-quinoxalin-2-ones Enabled by Visible-Light-Driven Difluoromethylation of Quinoxalin-2-ones
by: Kai-Zhong Fu, et al.
Published: (2022)

Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes
by: Fatmah Ali S. Alasmary, et al.
Published: (2024)

Synthesis, Biological Evaluation, and In Silico Modeling of <i>N</i>-Substituted Quinoxaline-2-Carboxamides
by: Ghada Bouz, et al.
Published: (2021)

Synthesis and Antimicrobial Activity of Some New Quinoxaline Derivatives
by: Ram Gopal Singhal, et al.
Published: (2010)

Synthesis, biological and computational evaluation of novel cyanomethyl vinyl ether derivatives
by: Endika Martín-Encinas, et al.
Published: (2024)

Discovery and SAR Study of Quinoxaline-Arylfuran Derivatives as a New Class of Antitumor Agents
by: Dongmei Fan, et al.
Published: (2022)

Synthesis of Some New Chalcone Compounds Derived From (Phenyl Quinoxaline Methyl Benzotriazol) of an Expected Biological Activity
by: Natiq Ahmed, et al.
Published: (1970)

Design, synthesis and evaluation of dihydro-1H-indene derivatives as novel tubulin polymerisation inhibitors with anti-angiogenic and antitumor potency
by: Shengtao Xu, et al.
Published: (2023)

Synthesis and Biological Evaluation of Some Newer 1H-Benzo[b][1,5]diazepin-2(3H)-one Derivatives as Potential Anticonvulsant Agents
by: Dinesh D Rishipathak, et al.
Published: (2022)

Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
by: Yi Le, et al.
Published: (2020)

Effect of FGFR alteration on prognosis in 1963 urothelial carcinoma patients with immune checkpoint inhibitors: Implying combination of FGFR inhibitor and immunotherapy for FGFR-altered urothelial carcinoma
by: Yuxuan Song, et al.
Published: (2024)

Design and Synthesis of Novel Nordihydroguaiaretic Acid (NDGA) Analogues as Potential FGFR1 Kinase Inhibitors With Anti-Gastric Activity and Chemosensitizing Effect
by: Qian Chen, et al.
Published: (2020)

Computational quest, synthesis and anticancer profiling of 3-methyl quinoxaline-2-one-based active hits against the tyrosine kinase
by: Priyadarsini Raj, et al.
Published: (2024)

Synthesis, biological evaluation and theoretical studies of (E)-1-(4-sulfamoyl-phenylethyl)-3-arylidene-5-aryl-1H-pyrrol-2(3H)-ones as human carbonic anhydrase inhibitors
by: Farhat Ramzan, et al.
Published: (2023)

Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development
by: Galina I. Buravchenko, et al.
Published: (2023)

Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives
by: Vincent Montero, et al.
Published: (2022)

Identification of Dihydropyrazolo[1,5-<i>a</i>]pyrazin-4(5<i>H</i>)-ones as Cyclic Products of β-Amidomethyl Vinyl Sulfone Alphavirus Cysteine Protease Inhibitors
by: Anirban Ghoshal, et al.
Published: (2024)

Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3]benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors
by: Guo-Liang Qiu, et al.
Published: (2018)

Design, synthesis and biological evaluation of erlotinib-based IDO1 inhibitors
by: Xi-xi Hou, et al.
Published: (2022)

Synthesis and antitumor activity of certain 2,3,6-trisubstituted quinazolin-4(3H)-one derivatives
by: Safinaz E. Abbas, et al.
Published: (2013)

The Evaluation of <i>FGFR1</i>, <i>FGFR2</i> and <i>FOXO1</i> in Orofacial Cleft Tissue
by: Jana Goida, et al.
Published: (2022)

Design, synthesis, and evaluation of novel N'-substituted-1-(4-chlorobenzyl)-1H-indol-3-carbohydrazides as antitumor agents
by: Le Cong Huan, et al.
Published: (2020)

Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11<i>H</i>-Indeno[1,2-<i>b</i>]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime
by: Vladislava V. Matveevskaya, et al.
Published: (2023)

Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors
by: Yumeng Wu, et al.
Published: (2020)

Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors
by: Abdallah E. Abdallah, et al.
Published: (2022)

1,6-Naphthyridin-2(1<i>H</i>)-ones: Synthesis and Biomedical Applications
by: Juan Marcos Oliveras, et al.
Published: (2021)

New spiro-indeno[1,2-b]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights
by: Assem Barakat, et al.
Published: (2023)

Synthesis and biological evaluation of novel 1,2,3-triazole hybrids of cabotegravir: identification of potent antitumor activity against lung cancer
by: Yajie Guo, et al.
Published: (2023)

Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives
by: Jean Guillon, et al.
Published: (2017)

Vinyl Theory
by: Di Leo, Jeffrey R.
Published: (2020)